Jasper Development Group LLC Secures Coveted Medical Marijuana Processor License in Alabama

Estimated reading time: 5 minutes

Press Release
Additional Resources
Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine
Testimonials and Public Relations
Latest Articles
Explore Our Articles
Free Ebook – Start Your Own Legal Cannabis Business

Press Release

JASPER, Ala, June 21, 2023

Catalyst Business Consulting (Catalyst BC) is thrilled to announce their client and partner, Jasper Development Group Inc. (JDG), has obtained a highly sought-after merit-based, limited license to process medical marijuana in Alabama from hundreds of applications. This monumental achievement marks a significant milestone for both Alabama locals, Jasper Development Group Inc., and the rapidly evolving medical cannabis industry in the state.

Alabama’s recent legalization of medical marijuana has created opportunities for businesses looking to enter the emerging cannabis market. JDG, a pioneering entity committed to advancing patient care, has positioned itself at the forefront of this burgeoning industry in a notably conservative state.

Under the guidance of Catalyst BC, JDG undertook a rigorous merit application process, demonstrating their unwavering dedication to patient care, compliance, safety, quality, consistency, and innovation in providing medical marijuana in Alabama. A managed, comprehensive approach and commitment to excellence enabled JDG to secure one of the limited medical marijuana processor licenses issued by the AMCC on Monday, June 12th.

The medical marijuana processor license will allow JDG to produce a wide range of pharmaceutical-grade cannabis products including tinctures, topicals, lozenges, balms, salves, and more. These products will benefit Alabama medical patients with qualifying condition symptoms and improve their quality of life. While the state currently limits those who can obtain medical cannabis and the types of products available for treatment, Catalyst BC and JDG are hopeful that this first license will lead to more options for medical cannabis for Alabama residents.

“This is an incredibly proud moment for JDG,” said Tyler Robinson, CEO of JDG. “We are immensely grateful for the expert guidance and strategic support provided by Catalyst BC throughout this process. This license is a testament to our mission of helping our neighbors in Alabama with research and innovation in the medical marijuana industry.”

As part of its mission, JDG will build and operate a state-of-the-art medical cannabis processing facility, adhering to quality control measures to ensure the production of safe, reliable, and efficacious medical cannabis products. The company’s progressive vision will extend beyond its operations as it intends to collaborate with local healthcare providers, educational institutions, and other stakeholders to foster awareness and encourage further research into the therapeutic potential of medical cannabis in Alabama.

Catalyst BC, a leading consulting firm specializing in the cannabis industry, played an instrumental role in supporting JDG throughout the application process. The Catalyst BC team’s expertise in navigating complex regulatory frameworks, the in-depth details of successful merit-based applications, and their deep industry knowledge has proven invaluable in securing this license for their client.

“We are honored to have been part of this journey with JDG’s internal team,” stated Ian Miller, CEO at Catalyst BC. “We are confident that JDG will contribute to Alabama’s medical cannabis landscape and the successful outcomes of its patients. This license award is a testament to the openness and will of Alabama’s voters and public servants and the dedication, professionalism, and vision of both JDG and Catalyst BC.”

The issuance of the medical marijuana processor license to JDG marks an exciting new chapter in Alabama’s evolving medical cannabis industry. The collaboration between Catalyst BC and JDG exemplifies the potential for transformative partnerships between focused subject matter experts and bold entrepreneurs in this emerging sector.

About Catalyst Business Consulting

Catalyst BC is a boutique global cannabis consulting and advisement firm established to support entrepreneurs, investors, and operators to activate and perform at an accelerated rate through science, data, and hands-on experience. The team at Catalyst BC includes a dynamic group of experienced business professionals and legacy cannabis operators with over 50 years of direct founder, operator, and advisor experience in regulated cannabis and vertical farming. Catalyst BC specializes in License Acquisition, Vertical Farming, Facility Design Assistance, and Operational Optimization/Turnaround, including Pre-Exit Optimization Services for cannabis and controlled environment agriculture (CEA) operations.

About Jasper Development Group Inc.

Owned and operated by Alabama natives, Jasper Development Group Inc. is a pioneering medical marijuana processor in the state. With a steadfast commitment to advancing patient care, research, and innovation, Jasper Development Group Inc. aims to provide pharmaceutical-grade cannabis products to improve the quality of life for patients suffering from qualifying medical conditions. They are dedicated to adhering to the highest safety standards, efficacy, affordability, and innovation, delivering enhanced quality of life, and supporting positive comprehensive health and wellness outcomes for Alabama’s medical cannabis patients.

This Press Release was first published on PRWeb.

Additional Resources

Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine

Testimonials and Public Relations

Latest Articles

New York Cannabis Provisional License (2026): From Provisional to Operational
For operators whose strength is growing cannabis, Virginia’s emerging adult-use market presents a significant opportunity – and a cultivation license is the gateway to it. The June 2026 framework authorizes the Virginia Cannabis Control Authority (CCA) to begin accepting license applications on or after February 1, 2027 and issuing licenses on or after May 1, 2027. It also establishes five cultivation tiers with maximum canopies ranging from 5,000 to 35,000 square feet.
New York Cannabis Proximity Rules (2026): Site Selection After the Correction
In New York cannabis retail, location is not a late-stage detail – it is a threshold licensing issue. A proposed dispensary can satisfy ownership and financial requirements and still fail because the site conflicts with a school, a house of worship, another dispensary, a municipal opt-out, or local zoning. The risk became unmistakable in 2025, when OCM concluded that its long-standing school-distance review did not match the wording of then-existing Cannabis Law § 72.
New York Cannabis Cultivation License & Canopy Expansion (2026)
For cultivators, New York in 2026 presents an unusual and genuinely interesting situation. The general application window is closed, but in March 2026 the Cannabis Control Board adopted Resolution 2026-19 directing OCM to process canopy-expansion amendment requests from existing adult-use cultivator licensees. The action followed OCM’s projection that the market could face a 356,000-pound supply gap in the 2026 growing season.
New York Processor Type 3 Branding License (2026): The Open White-Label Path
New York currently accepts Processor Type 3 Branding license applications year-round. For the right business, it can be an efficient way to establish a compliant brand presence in New York’s fast-growing adult-use market because it permits white-label agreements without requiring the brand licensee to operate a cannabis manufacturing facility. It does not, however, authorize the brand licensee to possess cannabis, manufacture products, distribute inventory, or sell directly to consumers.
New York Cannabis Microbusiness License (2026): The Limited-Vertical Path
In a market that otherwise generally separates the supply and retail tiers, the New York cannabis microbusiness license is a limited exception – and that makes it one of the most interesting and most misunderstood licenses in the state. It allows one small-scale operator to cultivate cannabis and conduct at least one additional authorized activity: processing, distribution, or retail sale.
How to Open a Dispensary in New York (2026): The Real Path Right Now
New York’s last adult-use application window closed in December 2023, and the Office of Cannabis Management (OCM) is still working through the roughly 7,000 applications it received then. That does not mean the door is shut – but it does mean the honest path into New York retail today looks very different from “fill out an application and wait.”

Table of contents